<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Pelthos Therapeutics</title>
    <link>https://www.biospace.com/employer/3076403/pelthos-therapeutics</link>
    <description>Pelthos Therapeutics</description>
    <language>en-US</language>
    <lastBuildDate>Wed, 03 Apr 2024 13:26:05 GMT</lastBuildDate>
    <atom:link href="https://www.biospace.com/employer/3076403/pelthos-therapeutics.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™</title>
      <link>https://www.biospace.com/ligand-pharmaceuticals-announces-launch-of-pelthos-therapeutics-to-accelerate-commercialization-of-zelsuvmi</link>
      <description>Ligand Pharmaceuticals (Nasdaq: LGND) today announced the launch of Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and the appointment of seasoned industry executive Scott Plesha to the role of Chief Executive Officer.</description>
      <pubDate>Wed, 03 Apr 2024 13:26:05 GMT</pubDate>
      <guid>https://www.biospace.com/ligand-pharmaceuticals-announces-launch-of-pelthos-therapeutics-to-accelerate-commercialization-of-zelsuvmi</guid>
    </item>
    <item>
      <title>Pelthos Therapeutics Establishes Board of Directors</title>
      <link>https://www.biospace.com/pelthos-therapeutics-establishes-board-of-directors</link>
      <description>Pelthos Therapeutics today announced it has appointed five seasoned industry professionals to serve on its Board of Directors.</description>
      <pubDate>Tue, 16 Apr 2024 14:16:05 GMT</pubDate>
      <guid>https://www.biospace.com/pelthos-therapeutics-establishes-board-of-directors</guid>
    </item>
    <item>
      <title>Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics</title>
      <link>https://www.biospace.com/press-releases/ligand-subsidiary-pelthos-therapeutics-to-combine-with-channel-therapeutics</link>
      <description />
      <pubDate>Thu, 17 Apr 2025 10:40:28 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/ligand-subsidiary-pelthos-therapeutics-to-combine-with-channel-therapeutics</guid>
    </item>
    <item>
      <title>Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement</title>
      <link>https://www.biospace.com/press-releases/channel-therapeutics-announces-reverse-common-stock-split-in-conjunction-with-the-close-of-the-merger-with-pelthos-therapeutics-and-concurrent-50-1-million-private-placement</link>
      <description />
      <pubDate>Fri, 27 Jun 2025 13:49:50 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/channel-therapeutics-announces-reverse-common-stock-split-in-conjunction-with-the-close-of-the-merger-with-pelthos-therapeutics-and-concurrent-50-1-million-private-placement</guid>
    </item>
    <item>
      <title>Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics</title>
      <link>https://www.biospace.com/press-releases/ligand-announces-completion-of-pelthos-therapeutics-merger-with-channel-therapeutics</link>
      <description />
      <pubDate>Thu, 03 Jul 2025 06:29:33 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/ligand-announces-completion-of-pelthos-therapeutics-merger-with-channel-therapeutics</guid>
    </item>
    <item>
      <title>Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement</title>
      <link>https://www.biospace.com/press-releases/pelthos-therapeutics-completes-merger-with-channel-therapeutics-and-closes-50-1-million-private-placement</link>
      <description />
      <pubDate>Thu, 03 Jul 2025 06:28:22 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/pelthos-therapeutics-completes-merger-with-channel-therapeutics-and-closes-50-1-million-private-placement</guid>
    </item>
    <item>
      <title>Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™</title>
      <link>https://www.biospace.com/press-releases/ligand-partner-pelthos-therapeutics-launches-zelsuvmi</link>
      <description />
      <pubDate>Fri, 11 Jul 2025 07:46:07 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/ligand-partner-pelthos-therapeutics-launches-zelsuvmi</guid>
    </item>
    <item>
      <title>Pelthos Therapeutics Launches ZELSUVMI™ (berdazimer) Topical Gel 10.3%, the First and Only FDA-Approved At-Home Treatment for Molluscum Contagiosum</title>
      <link>https://www.biospace.com/press-releases/pelthos-therapeutics-launches-zelsuvmi-berdazimer-topical-gel-10-3-the-first-and-only-fda-approved-at-home-treatment-for-molluscum-contagiosum</link>
      <description />
      <pubDate>Fri, 11 Jul 2025 07:44:01 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/pelthos-therapeutics-launches-zelsuvmi-berdazimer-topical-gel-10-3-the-first-and-only-fda-approved-at-home-treatment-for-molluscum-contagiosum</guid>
    </item>
    <item>
      <title>Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update</title>
      <link>https://www.biospace.com/press-releases/pelthos-therapeutics-reports-second-quarter-2025-financial-results-for-legacy-operations-and-provides-business-update</link>
      <description />
      <pubDate>Tue, 19 Aug 2025 06:55:28 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/pelthos-therapeutics-reports-second-quarter-2025-financial-results-for-legacy-operations-and-provides-business-update</guid>
    </item>
    <item>
      <title>Pelthos Therapeutics to Participate in the 2025 Wells Fargo Healthcare Conference</title>
      <link>https://www.biospace.com/press-releases/pelthos-therapeutics-to-participate-in-the-2025-wells-fargo-healthcare-conference</link>
      <description />
      <pubDate>Wed, 03 Sep 2025 10:38:20 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/pelthos-therapeutics-to-participate-in-the-2025-wells-fargo-healthcare-conference</guid>
    </item>
  </channel>
</rss>
